Crossmark

Gut microbiome remodeling across hepatocellular carcinoma progression and transarterial chemoembolization is associated with therapeutic response and prognosis

Crossref DOI link: https://doi.org/10.1007/s10238-026-02137-z

Published Online: 2026-04-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Bing

Wan, Shu-Hui

Zhang, Yi-Tian

Lin, Jun-Hao

Ke, Xun-Chang

Lin, Wei-Hua

Zhan, Mei-Xiao
Funding

Funding for this research was provided by:

Guangdong Basic and Applied Basic Research Foundation (2023A1515012588 and 2022A1515220092)

Guangdong Basic and Applied Basic Research Foundation (2022B1515020010)

the National Natural Science Foundation of China (82472084)

the National Natural Science Foundation of China (82272103)

the Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment (2021B1212040004)
License Information

Text and Data Mining valid from 2026-04-03

Accepted Manuscript valid from 2026-04-03
More Information

Article History

Received: 25 February 2026

Accepted: 15 March 2026

First Online: 3 April 2026

Declarations

:

: The authors declare no competing interests.

: The study protocol was approved by the Ethics Committee of Zhuhai People’s Hospital (Approval No. 2021-IRB-14).

: All participants provided written informed consent prior to their inclusion in the study. All procedures were conducted in accordance with the principles of the Declaration of Helsinki.

: All participants provided written informed consent for the publication of this study.

Document is current

Any future updates will be listed below